Search

everythinglearnresearchcommunity

for

Search:↓

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Treat pattern hair loss with finasteride and topical minoxidil.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Non-obese women with hair loss have higher heart disease risk.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Various treatments exist for hair loss, but more research is needed for better options.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Androgens can cause hair growth in some areas but hair loss on the scalp.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.